Mork Capital Management’s Pfizer PFE Stock Holding History

Mork Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Hold	44,020	–	–	0.68%	77
2026 Q1	$1.24M	Hold	44,020	–	–	0.88%	46
2025 Q4	$1.1M	Buy	+44,020	New	+$1.11M	0.67%	60
2024 Q4	–	Sell	-34,710	Closed	-$1M	–	133
2024 Q3	$1M	Hold	34,710	–	–	0.72%	76
2024 Q2	$971K	Hold	34,710	–	–	0.76%	70
2024 Q1	$963K	Hold	34,710	–	–	0.73%	85
2023 Q4	$999K	Buy	+34,710	New	+$1.05M	0.61%	70

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mork Capital Management's PFE Position: Q2 2026 in Review

Mork Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 44,020 shares worth $1.06M. The position accounts for 0.68% of the portfolio, ranked #77.

Mork Capital Management first reported a position in PFE in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.24M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Mork Capital Management held 44,020 shares of Pfizer worth $1.06M as of Q2 2026.
Mork Capital Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.68% of Mork Capital Management's portfolio in Q2 2026, its #77 holding.
Mork Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 7 quarters since.
Mork Capital Management's Pfizer position peaked at $1.24M in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mork Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.